Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to survey the type and the amount of non-resuscitation fluids that patients with septic shock receives during their first 5 days of ICU admission.
Background: Several studies indicate that a large part of the fluid intake in intensive care patients consists of fluids that are given for indications other than volume expansion. However, the type of non-resuscitation fluids that hemodynamically unstable ICU patients receive has not been well characterized.
Methods: A multicenter observational cohort study. Baseline data including, sex, age, physiological data at admission, source of sepsis, illness severity, and ICU and hospital mortality will be collected.
Fluids administered during the first five days of ICU admission will be registered. Fluids used as vehicle to administer drugs will be regarded as non-resuscitation fluids and will be characterized in detail. All glucose solutions will be regarded as non-resuscitation fluids. Crystalloids delivered at a rate of < 5 ml/kg/h will be considered as non-resuscitation fluids. Parenteral nutrition will be regarded as non-resuscitation fluids. Crystalloids delivered at a rate of ≥ 5 ml/kg/h will be considered to be resuscitation fluids. Blood products and colloids will be regarded as resuscitation fluids.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Type, indication and volume of fluids given to septic shock patients for other reasons than circulatory support. | Type of fluid is defined as either 0.9% normal saline, glucose, Ringers acetate/lactate, enteral nutrition, parenteral nutrition or sterile water. Indication is defined as vehicle, nutrition, maintenance or other. Volume will be reported in ml. | First five days in ICU |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
• Lack of informed consent (see above)
Not provided
Not provided
Not provided
Consecutive patients admitted with septic shock during a 4 month period in ICUs in Sweden and in British Columbia, Canada. A maximum of 30 patients per centre will be recruited.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Peter Bentzer, MD, PhD | Lund University, Lund, Sweden | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St Paul's Hospital | Vancouver | British Columbia | Canada | |||
| Vancouver General Hospital |
On reasonable request
Study protocol can be shared from March 1st. Clinical Study Report (CSR) can be shared as data analysis is complete.
On reasonable request
Not provided
Not provided
| ID | Term |
|---|---|
| D012772 | Shock, Septic |
| ID | Term |
|---|---|
| D018805 | Sepsis |
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
Not provided
Not provided
Not provided
Not provided
Not provided
| Vancouver |
| British Columbia |
| Canada |
| ICU Halmstad Hospital | Halmstad | Sweden |
| ICU Helsingborg Hospital | Helsingborg | Sweden |
| ICU Kristianstad Hospital | Kristianstad | Sweden |
| ICU Skane University Hospital | Lund | Sweden |
| Department of Infections Diseases | Malmö | Sweden |
| ICU Skane University Hospital | Malmö | Sweden |
| ICU Ystad Hospital | Ystad | Sweden |
| D010335 |
| Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012769 | Shock |